About HANARO BIO KOREA ACTIVE

498050 invests in stocks. The fund's major sectors are Health Technology, with 93.75% stocks, and Health Services, with 4.19% of the basket. The assets are mostly located in the Asia region.

498050 top holdings are ALTEOGEN Inc. and ABL Bio, Inc., occupying 13.36% and 10.44% of the portfolio correspondingly.

498050 assets under management is ‪83.45 M‬ KRW. It's risen 11.64% over the last month.

498050 fund flows account for ‪−11.15 M‬ KRW (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.

498050 shares are issued by HANWHA LIFE INSURANCE Co., Ltd. under the brand NH-Amundi. The ETF was launched on Nov 26, 2024, and its management style is Active.

498050 follows the No Underlying Index. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.

498050 invests in stocks.

498050 price has risen by 7.77% over the last month, and its yearly performance shows a 14.54% increase. See more dynamics on 498050 price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 8.97% over the last month, showed a 4.54% increase in three-month performance and has increased by 12.03% in a year.